Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions


Answer 2
  1. Decrease the serum uric acid level to less than 6.0 mg/dL. Decreasing the serum uric acid level is an important (and often overlooked) part of gout management. The maximum solubility of urate in serum is approximately 6.7 mg/dL. After initiating uric acid-lowering therapy, it is important to recheck the patient’s serum uric acid level to ensure that the goal is reached. At levels less than 6.0 mg/dL, uric acid stops accumulating in soft tissues and joints and the total body uric acid load begins to decrease. If uric acid remains high, uric acid-lowering therapy should be adjusted and the patient should be reevaluated.2

    2. Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004;51:321-5.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 8/20/07 • kkj